Search SEC
Fundamental Analysis
351 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AUPHAurinia Pharmaceuticals Inc. | 91 | 100 | 100 | 91 | +19.76% | +33.2% | n/a | +90.72% | -2.91% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ELTPELITE PHARMACEUTICALS INC /NV/ | 84.9 | 100 | 100 | 91 | +107.85% | +73.84% | n/a | +16.82% | +5.65% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| NAGENiagen Bioscience, Inc. | 84.4 | 61.7 | 37 | 91 | +25.17% | +117.43% | n/a | +40.37% | -0.87% | 0% | 0 | n/a | 14.88x | Gross margin expansion, Operating leverage, Net debt reduction, Share count reduction, Strong operating leverage2 warnings |
| LQDTLIQUIDITY SERVICES INC | 74.2 | 60.6 | 76.4 | 100 | +15.96% | +31.15% | +21.51% | n/a | +1.02% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Strong operating leverage |
| TBPHTheravance Biopharma, Inc. | 86.6 | 100 | 100 | 85 | +35.11% | n/a | n/a | +101.38% | +1.86% | 0% | 0 | n/a | 16.35x | Operating leverage, Net debt reduction |
| DTDynatrace, Inc. | 78.9 | 73.6 | 70.2 | 91 | +42.69% | +12.58% | n/a | +4.95% | -3.2% | 0% | 0 | n/a | 95.79x | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| NGSNATURAL GAS SERVICES GROUP INC | 86.8 | n/a | n/a | 83 | +258.85% | +11.79% | n/a | +54.34% | +1.83% | 1.57% | 2 | 13.23% | n/a | Net debt reduction |
| MEDPMedpace Holdings, Inc. | 82.4 | 51.9 | 71.1 | 86 | +25.63% | +167.16% | n/a | +3.22% | -8.47% | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| TILEINTERFACE INC | 77.2 | 72.4 | 80.1 | 91 | +14.77% | +21.01% | n/a | +5.93% | -1.48% | 0.32% | 20 | 3.07% | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ANIPANI PHARMACEUTICALS INC | 83.5 | 93.6 | 96.2 | 83 | +51.82% | +16.93% | n/a | +35.17% | +9.32% | 0% | 0 | 1.48% | 17.7x | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| VCELVericel Corp | 74.9 | 100 | 99.6 | 90 | +29% | -2.12% | n/a | +15.02% | +4.82% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction |
| CLSCELESTICA INC | 79.4 | 67.8 | 67.8 | 85 | +52.15% | +69.53% | +60.47% | n/a | -0.6% | 0% | 0 | n/a | 42.46x | Gross margin expansion, Operating leverage, FCF growth, Net debt reduction, Share count reduction, Strong operating leverage1 warning |
| AITXArtificial Intelligence Technology Solutions Inc. | 80 | 100 | 100 | 83 | +55.59% | n/a | n/a | +803.19% | -97.32% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, Share count reduction1 warning |
| HRMYHarmony Biosciences Holdings, Inc. | 77.3 | 44 | 44 | 86 | +31.28% | +43.62% | n/a | +13.95% | +0.39% | 0% | 0 | n/a | 11.73x | Net debt reduction1 warning |
| ADIANALOG DEVICES INC | 66.5 | 100 | 91.3 | 100 | +43.54% | +10.32% | +49.87% | +9.34% | -1.88% | 1.03% | 24 | 52.93% | 52.75x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Share count reduction, Strong operating leverage1 warning |
| VNCEVINCE HOLDING CORP. | 72.1 | 80.3 | 88.2 | 91 | +12.07% | +30.6% | n/a | +10.45% | +2.88% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage |
| PSMTPRICESMART INC | 64.4 | 49.9 | 48.3 | 100 | +10.39% | +18.01% | -21.99% | +0.68% | +0.67% | 0.82% | 20 | 26.19% | 31.48x | Net debt reduction2 warnings |
| ACADACADIA PHARMACEUTICALS INC | 70.4 | 44 | 44 | 89 | +18.75% | +30.37% | n/a | n/a | +3.09% | 0% | 0 | n/a | 25.82x | Gross margin expansion, Net debt reduction1 warning |
| XBIOXenetic Biosciences, Inc. | 80.9 | 100 | 100 | 78 | +26.16% | n/a | n/a | +383.17% | +48.78% | 0% | 0 | n/a | n/a | Operating leverage, Net debt reduction1 warning |
| CENTCENTRAL GARDEN & PET CO | 62.3 | 59.3 | 61.7 | 100 | -0.58% | +14.22% | +300.7% | +3.33% | -4.52% | 0% | 0 | n/a | 9.1x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| CENTACENTRAL GARDEN & PET CO | 62.3 | 59.3 | 61.7 | 100 | -0.58% | +14.22% | +300.7% | +3.33% | -4.52% | 0% | 0 | n/a | 7.83x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| NGVCNatural Grocers by Vitamin Cottage, Inc. | 64.9 | 52.3 | 49.9 | 96 | +4.15% | +23.81% | -67.69% | +1.97% | -0.04% | 1.96% | 8 | 23.7% | n/a | Gross margin expansion, Operating leverage, Net debt reduction, Share count reduction, Strong operating leverage2 warnings |
| PUREPURE BIOSCIENCE, INC. | 68.2 | 100 | 100 | 90 | +15.41% | n/a | n/a | +122.86% | -0.92% | 0% | 0 | n/a | n/a | Operating leverage, Net debt reduction, Share count reduction1 warning |
| RNGRingCentral, Inc. | 67.3 | 83.4 | 90 | 91 | +6.77% | +25.1% | n/a | +27.6% | -4.83% | 0.35% | 1 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction |
| CRMSalesforce, Inc. | 60.9 | 59.9 | 58.3 | 100 | +13.89% | +11.25% | -30.03% | +19.35% | -15.36% | 0.74% | 3 | 21.28% | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Share count reduction, Strong operating leverage3 warnings |
1-25 of 351